Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer
Clinical trial NCT00308529 · COMPLETED
Trial details
- NCT number
- NCT00308529
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-03-01
- Primary completion
- 2007-04-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.